Market Tracker

02/17 5:16pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.55
Delayed Data
As of Feb 17
 +0.1067 / +24.07%
Today’s Change
0.28
Today|||52-Week Range
1.12
+78.34%
Year-to-Date

Today’s Trading

Previous close0.44
Today’s open0.45
Day’s range0.45 - 0.66
Volume27,005,991
Average volume (3 months)2,131,308
Market cap$141.4M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+58.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book2.60

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...0.000.00%
DRRXDURECT Corp+0.02+2.26%
IMDZImmune Design Corp-0.25-4.35%
FBIOFortress Biotech Inc+0.01+0.35%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 10, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts